The immunophilin FKBP51 (see Figure 6A) belongs to the class of FK506-binding proteins and is a potentially important drug target in the context of depression, obesity-related diabetes, and chronic pain [38,39]. This evidence concerns the gene FKBP4 and obesity disorder.